Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study
- 1 November 2000
- journal article
- clinical trial
- Published by Elsevier in Digestive and Liver Disease
- Vol. 32 (8) , 667-672
- https://doi.org/10.1016/s1590-8658(00)80327-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Evaluation of treatment regimens to cure Helicobacter pylori infection—a meta‐analysisAlimentary Pharmacology & Therapeutics, 1999
- The effect of antibiotic resistance on the outcome of three 1‐week triple therapies against Helicobacter pyloriAlimentary Pharmacology & Therapeutics, 1999
- Treatment options for Helicobacter pylori infection when proton pump inhibitor‐based triple therapy fails in clinical practiceAlimentary Pharmacology & Therapeutics, 1999
- Clinical relevance of resistant strains of Helicobacter pylori: a review of current dataGut, 1998
- Failed Treatment of Helicobacter pylori Infection Associated with Resistance to ClarithromycinHelicobacter, 1997
- Short‐course therapy with amoxycillin–clarithromycin triple therapy for 10 days (ACT‐10) eradicates Helicobacter pylori and heals duodenal ulcerAlimentary Pharmacology & Therapeutics, 1997
- Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.Gut, 1997
- Metronidazole Resistance Reduces Efficacy of Triple Therapy and Leads to Secondary Clarithromycin ResistanceDigestive Diseases and Sciences, 1997
- Eradication of Helicobacter pylori Using One‐week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I StudyHelicobacter, 1996
- The Sydney System: Histological divisionJournal of Gastroenterology and Hepatology, 1991